Search Results - "Gao, Yingsheng"
-
1
Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
Published in Marine drugs (02-07-2019)“…Nonalcoholic fatty liver disease (NAFLD) is a global epidemic, and there is no standard and efficient therapy for it. Chitosan oligosaccharide (COS) is widely…”
Get full text
Journal Article -
2
The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses
Published in Frontiers in pharmacology (29-04-2024)“…TT-01025-CL is an oral, irreversible small molecule that potently inhibits vascular adhesion protein-1 (VAP-1) for the treatment of inflammation associated…”
Get full text
Journal Article -
3
Discovery of a novel orally bioavailable NLRP3 inflammasome inhibitor, TTS-X, for potential treatment of inflammatory bowel disease
Published in The Journal of immunology (1950) (01-05-2023)“…Abstract Inappropriate activation of the NLRP3 inflammasome has been implicated in multiple inflammatory diseases, including inflammatory bowel disease…”
Get full text
Journal Article -
4
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Published in Journal of oncology (01-01-2019)“…Background. Although immunotherapy has recently achieved clinical successes in a variety of cancers, thus far there is no immunotherapeutic strategy for breast…”
Get full text
Journal Article -
5
Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans
Published in Cell metabolism (05-12-2023)“…Metabolic dysfunction-associated steatohepatitis (MASH) is a leading risk factor for liver cirrhosis and hepatocellular carcinoma. Here, we report that CHRNA4,…”
Get more information
Journal Article -
6
Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis
Published in Liver international (01-03-2020)“…Background & Aims Nonalcoholic fatty liver disease encompasses isolated steatosis or nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH). NASH…”
Get full text
Journal Article -
7
-
8
715 ARYL HYDROCARBON RECEPTOR DEFICIENCY IN INTESTINAL EPITHELIAL CELLS AGGRAVATES ALCOHOL-RELATED LIVER DISEASE
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2021)Get full text
Journal Article -
9
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
Published in Cellular and molecular gastroenterology and hepatology (01-01-2022)“…The ligand-activated transcription factor, aryl hydrocarbon receptor (AHR) can sense xenobiotics, dietary, microbial, and metabolic cues. Roles of Ahr in…”
Get full text
Journal Article -
10
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver DiseaseSummary
Published in Cellular and molecular gastroenterology and hepatology (01-01-2022)“…Background & Aims: The ligand-activated transcription factor, aryl hydrocarbon receptor (AHR) can sense xenobiotics, dietary, microbial, and metabolic cues…”
Get full text
Journal Article -
11
TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer
Published in Current cancer drug targets (2018)“…Epithelial to mesenchymal transition (EMT) is a major determinant of cancer metastasis and is closely linked with TGF-β1. Intracellular proteins, including E…”
Get more information
Journal Article